

Fundamental dimension Equity attribute | ANNXPeer $3.75▼-1.57% Cap $614.4MP/E -3.2x QuantScore39/100 | ABVXLeader $88.01▼-2.46% Cap $7.68BP/E -16.7x QuantScore55/100 | ACIUPeer $2.42▼-3.20% Cap $246.3MP/E -4.6x QuantScore41/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
48/100 |
46/100 |
26/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 50/100 | 63/100 | 21/100 |
Growth Revenue / earnings growth & margins | 0/100 | 50/100 | 40/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 83/100 | 83/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -3.2x | -16.7x | -4.6x |
Forward P/E (next FY) | -3.6x | -24.2x | -5.7x |
EV / EBITDA (TTM) | -2.2x | -23.2x | -4.3x |
Price / Sales | — | -3405.2x | 11.6x |
Price / Free Cash Flow | -3.2x | -46.5x | -5.8x |
PEG ratio | -0.37 | 0.30 | 0.23 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | -1.51 (Distress) | 38.34 (Safe) | -4.02 (Distress) |
Total debt / equity | 0.13 | 0.00 | 0.12 |
Quick ratio | 5.5x | 6.0x | 0.9x |
Interest coverage | — | -9.4x | -263.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | -86.9% |
Net income growth YoY | -49.6% | -90.7% | -38.4% |
Gross margin (TTM) | 0.0% | 153.1% | 100.0% |
Operating margin (FY) | — | — | -1927.3% |
FCF margin (FY) | — | — | -1875.4% |
5. Trailing price performancePrice change over period |
1M return | -1.3% | -7.2% | -9.0% |
3M return | -28.2% | -30.0% | +8.5% |
6M return | -36.2% | -23.2% | -14.8% |
Year to date | -25.3% | -34.7% | -22.9% |
1Y return | +16.8% | -3.0% | -25.5% |
3Y return | +106.0% | +907.0% | -13.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.789 -79.0% premium | $7.17 -91.9% premium | $-0.0415 -101.7% premium |
Wall Street consensus target | $10.50 +180.0% · range $7.00–$14.00 | $156.00 +77.3% · range $118.00–$180.00 | $8.33 +244.2% · range $7.00–$10.00 |
Consensus stance | 91% Buy9% Hold0% Sell | 92% Buy8% Hold0% Sell | 89% Buy11% Hold0% Sell |